Kahraman, R. Et Al. 2017. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. Therapeutics and Clinical Risk Management , vol.13 , 1295-1301.

Kahraman, R., Calhan, T., Sahin, A., Ozdil, K., Caliskan, Z., Bireller, E. S., ... ÇAKMAKOĞLU, B.(2017). Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. Therapeutics and Clinical Risk Management , vol.13, 1295-1301.

Kahraman, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?," Therapeutics and Clinical Risk Management , vol.13, 1295-1301, 2017

Kahraman, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." Therapeutics and Clinical Risk Management , vol.13, pp.1295-1301, 2017

Kahraman, R. Et Al. (2017) . "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." Therapeutics and Clinical Risk Management , vol.13, pp.1295-1301.

@article{article, author={Resul Kahraman Et Al. }, title={Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?}, journal={Therapeutics and Clinical Risk Management}, year=2017, pages={1295-1301} }